Suppr超能文献

克罗恩病:后续随访

Crohn's disease: the subsequent visit.

作者信息

Manolakis Catherine S, Farraye Francis A, Di Palma Jack A

机构信息

Dr. Manolakis is a Fellow in the Division of Gastroenterology and a Clinical Instructor in Medicine at the University of South Alabama College of Medicine in Mobile, Alabama. Dr. Farraye is a Professor in the Department of Gastroenterology at Boston University School of Medicine in Boston, Massachusetts. Dr. Di Palma is a Professor of Medicine, Director of the USA Digestive Health Center, and Director of the Division of Gastroenterology, all at the University of South Alabama College of Medicine in Mobile, Alabama.

出版信息

Gastroenterol Hepatol (N Y). 2013 Jan;9(1):16-20.

Abstract

The diagnosis and subsequent management of Crohn's disease are challenging for both the patient and the gastroenterologist. After the initial assessment, subsequent visits should assess the patient's readiness to begin therapy, monitor progress if therapy has been initiated, assess for complications of the disease or therapy, and ensure that all appropriate health maintenance measures are current. This article is intended to be a companion to our earlier paper "Crohn's Disease: The First Visit," which was published in Gastroenterology & Hepatology in March 2011. This article will offer a methodologic and sequential approach to subsequent office visits, as well as provide a checklist for the assessment of Crohn's disease.

摘要

克罗恩病的诊断及后续治疗对患者和胃肠病学家而言都颇具挑战。在初始评估之后,后续的就诊应评估患者开始治疗的意愿,若已开始治疗则监测进展情况,评估疾病或治疗的并发症,并确保所有适当的健康维护措施均已落实。本文旨在作为我们之前发表于2011年3月《胃肠病学与肝病学》杂志的论文《克罗恩病:初诊》的补充。本文将提供一种针对后续门诊就诊的方法学和循序渐进的方法,并给出一份克罗恩病评估清单。

相似文献

1
Crohn's disease: the subsequent visit.
Gastroenterol Hepatol (N Y). 2013 Jan;9(1):16-20.
2
Crohn's disease: the first visit.
Gastroenterol Hepatol (N Y). 2011 Mar;7(3):163-9.
5
Optimising monitoring in the management of Crohn's disease: a physician's perspective.
J Crohns Colitis. 2013 Sep;7(8):653-69. doi: 10.1016/j.crohns.2013.02.005. Epub 2013 Apr 4.
6
Maintenance of remission in Crohn's disease: current and emerging therapeutic options.
Drugs. 2004;64(10):1069-89. doi: 10.2165/00003495-200464100-00004.
7
Natalizumab for induction of remission in Crohn's disease.
Cochrane Database Syst Rev. 2007 Jan 24(1):CD006097. doi: 10.1002/14651858.CD006097.pub2.
8
Natalizumab for induction of remission in Crohn's disease.
Cochrane Database Syst Rev. 2006 Jul 19(3):CD006097. doi: 10.1002/14651858.CD006097.
9
Anorectal Crohn's disease: surgical and medical management.
BioDrugs. 2000 Feb;13(2):95-105. doi: 10.2165/00063030-200013020-00003.
10
Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.
Tech Coloproctol. 2017 Sep;21(9):683-691. doi: 10.1007/s10151-017-1684-y. Epub 2017 Sep 19.

引用本文的文献

1
Preventive health measures in inflammatory bowel disease.
World J Gastroenterol. 2016 Sep 14;22(34):7625-44. doi: 10.3748/wjg.v22.i34.7625.
2
Health maintenance and inflammatory bowel disease.
Curr Gastroenterol Rep. 2014 Oct;16(10):402. doi: 10.1007/s11894-014-0402-4.

本文引用的文献

1
Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
Gastroenterology. 2012 Aug;143(2):390-399.e1. doi: 10.1053/j.gastro.2012.05.004. Epub 2012 May 11.
2
Health maintenance in the inflammatory bowel disease patient.
Gastroenterol Clin North Am. 2012 Jun;41(2):325-37. doi: 10.1016/j.gtc.2012.01.006. Epub 2012 Feb 24.
3
Recommended adult immunization schedule: United States, 2012.
Ann Intern Med. 2012 Feb 7;156(3):211-7. doi: 10.7326/0003-4819-156-3-201202070-00388. Epub 2012 Jan 31.
4
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study.
Inflamm Bowel Dis. 2012 Jun;18(6):1042-7. doi: 10.1002/ibd.21800. Epub 2011 Jun 14.
5
Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge.
Inflamm Bowel Dis. 2011 Dec;17(12):2536-40. doi: 10.1002/ibd.21667. Epub 2011 Apr 28.
6
Crohn's disease: the first visit.
Gastroenterol Hepatol (N Y). 2011 Mar;7(3):163-9.
7
Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines.
Inflamm Bowel Dis. 2012 Feb;18(2):261-8. doi: 10.1002/ibd.21688. Epub 2011 Mar 15.
8
Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.
Aliment Pharmacol Ther. 2011 Mar;33(6):619-33. doi: 10.1111/j.1365-2036.2010.04570.x.
10
Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients?
Dig Dis Sci. 2011 Mar;56(3):819-24. doi: 10.1007/s10620-010-1329-8. Epub 2010 Jul 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验